102 related articles for article (PubMed ID: 7610664)
1. [Growth inhibition of Borrelia burgdorferi sensu lato by antibodies. A contribution to understanding the pathogenesis and improving diagnosis of Lyme borreliosis].
Sadziene A; Barbour AG
Wien Med Wochenschr; 1995; 145(7-8):162-5. PubMed ID: 7610664
[TBL] [Abstract][Full Text] [Related]
2. Borrelia burgdorferi mutant lacking Osp: biological and immunological characterization.
Sadziene A; Thomas DD; Barbour AG
Infect Immun; 1995 Apr; 63(4):1573-80. PubMed ID: 7890424
[TBL] [Abstract][Full Text] [Related]
3. Inability of truncated recombinant Osp A proteins to elicit protective immunity to Borrelia burgdorferi in mice.
Bockenstedt LK; Fikrig E; Barthold SW; Kantor FS; Flavell RA
J Immunol; 1993 Jul; 151(2):900-6. PubMed ID: 8335917
[TBL] [Abstract][Full Text] [Related]
4. Polymerase chain reaction in diagnosis of Borrelia burgdorferi infections and studies on taxonomic classification.
Lebech AM
APMIS Suppl; 2002; (105):1-40. PubMed ID: 11985118
[TBL] [Abstract][Full Text] [Related]
5. Functional heterogeneity in the antibodies produced to Borrelia burgdorferi.
Benach JL
Wien Klin Wochenschr; 1999 Dec; 111(22-23):985-9. PubMed ID: 10666815
[TBL] [Abstract][Full Text] [Related]
6. Growth-inhibiting antibody responses of humans vaccinated with recombinant outer surface protein A or infected with Borrelia burgdorferi or both.
Luke CJ; Marshall MA; Zahradnik JM; Bybel M; Menefee BE; Barbour AG
J Infect Dis; 2000 Mar; 181(3):1062-8. PubMed ID: 10720532
[TBL] [Abstract][Full Text] [Related]
7. DNA vaccines expressing a fusion product of outer surface proteins A and C from Borrelia burgdorferi induce protective antibodies suitable for prophylaxis but Not for resolution of Lyme disease.
Wallich R; Siebers A; Jahraus O; Brenner C; Stehle T; Simon MM
Infect Immun; 2001 Apr; 69(4):2130-6. PubMed ID: 11254567
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Borrelia burgdorferi sensu lato strains isolated from Ixodes ricinus in Mecklenburg-Vorpommern, Germany.
Lottmann H; Wilske B; Herrmann H
Med Microbiol Immunol; 1996 Feb; 184(4):181-4. PubMed ID: 8811650
[TBL] [Abstract][Full Text] [Related]
9. Detection of Borrelia burgdorferi-specific CD8+ cytotoxic T cells in patients with Lyme arthritis.
Busch DH; Jassoy C; Brinckmann U; Girschick H; Huppertz HI
J Immunol; 1996 Oct; 157(8):3534-41. PubMed ID: 8871653
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of decorin-binding protein A (DbpA) reveals five major groups among European Borrelia burgdorferi sensu lato strains with impact for the development of serological assays and indicates lateral gene transfer of the dbpA gene.
Schulte-Spechtel U; Fingerle V; Goettner G; Rogge S; Wilske B
Int J Med Microbiol; 2006 May; 296 Suppl 40():250-66. PubMed ID: 16530482
[TBL] [Abstract][Full Text] [Related]
11. A LightCycler TaqMan assay for detection of Borrelia burgdorferi sensu lato in clinical samples.
Ivacic L; Reed KD; Mitchell PD; Ghebranious N
Diagn Microbiol Infect Dis; 2007 Feb; 57(2):137-43. PubMed ID: 16989975
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of an internally controlled real-time PCR targeting the ospA gene for detection of Borrelia burgdorferi sensu lato DNA in cerebrospinal fluid.
Gooskens J; Templeton KE; Claas EC; van Dam AP
Clin Microbiol Infect; 2006 Sep; 12(9):894-900. PubMed ID: 16882295
[TBL] [Abstract][Full Text] [Related]
13. [Immunochemical analysis of the immune response in late manifestations of Lyme borreliosis].
Wilske B; Preac-Mursic V; Schierz G; Gueye W; Herzer P; Weber K
Zentralbl Bakteriol Mikrobiol Hyg A; 1988 Mar; 267(4):549-58. PubMed ID: 3381603
[TBL] [Abstract][Full Text] [Related]
14. Improving the specificity of 16S rDNA-based polymerase chain reaction for detecting Borrelia burgdorferi sensu lato-causative agents of human Lyme disease.
Cyr TL; Jenkins MC; Hall RD; Masters EJ; McDonald GA
J Appl Microbiol; 2005; 98(4):962-70. PubMed ID: 15752343
[TBL] [Abstract][Full Text] [Related]
15. Molecular characterization of the OspA(161-175) T cell epitope associated with treatment-resistant Lyme arthritis: differences among the three pathogenic species of Borrelia burgdorferi sensu lato.
Drouin EE; Glickstein LJ; Steere AC
J Autoimmun; 2004 Nov; 23(3):281-92. PubMed ID: 15501399
[TBL] [Abstract][Full Text] [Related]
16. [Diagnosis of Lyme borreliosis with western blotting].
Hulínská D
Epidemiol Mikrobiol Imunol; 1997 Mar; 46(1):3-8. PubMed ID: 9162453
[TBL] [Abstract][Full Text] [Related]
17. Molecular mapping of Osp-A mediated immunity against Borrelia burgdorferi, the agent of Lyme disease.
Sears JE; Fikrig E; Nakagawa TY; Deponte K; Marcantonio N; Kantor FS; Flavell RA
J Immunol; 1991 Sep; 147(6):1995-2000. PubMed ID: 1716290
[TBL] [Abstract][Full Text] [Related]
18. Direct demonstration of antigenic substitution of Borrelia burgdorferi ex vivo: exploration of the paradox of the early immune response to outer surface proteins A and C in Lyme disease.
Montgomery RR; Malawista SE; Feen KJ; Bockenstedt LK
J Exp Med; 1996 Jan; 183(1):261-9. PubMed ID: 8551229
[TBL] [Abstract][Full Text] [Related]
19. Sera from patients with chronic Lyme disease protect mice from Lyme borreliosis.
Fikrig E; Bockenstedt LK; Barthold SW; Chen M; Tao H; Ali-Salaam P; Telford SR; Flavell RA
J Infect Dis; 1994 Mar; 169(3):568-74. PubMed ID: 8158028
[TBL] [Abstract][Full Text] [Related]
20. Identification of a highly cross-reactive outer surface protein B epitope among diverse geographic isolates of Borrelia spp. causing Lyme disease.
Shoberg RJ; Jonsson M; Sadziene A; Bergström S; Thomas DD
J Clin Microbiol; 1994 Feb; 32(2):489-500. PubMed ID: 7512097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
